Cellebrite DI Ltd. CLBT

CLBT’s stock has fallen about 35% YTD despite revenue of $514.3 million and net income of $58.2 million from its digital investigations platform. The company is increasingly moving to a recurring, subscription-based model, with over 90% of revenue now SaaS/Cloud, improving visibility, margins, and cash flow. A ‘Fair Value’ narrative pegs value at roughly $15.36, implying the shares look undervalued at around $11.56, though growth assumptions and a high forward earnings multiple temper enthusiasm. Analysts’ targets cluster near $15.36, contingent on stronger 2029 earnings. Simply Wall St also notes the stock trades below its modeled cash flow value and cites a low value score and relative P/E weakness versus peers. Risks cited include reliance on US federal budgets and rising privacy regulation that could disrupt ARR growth and the subscription narrative. The piece ends with cautions and competitive-valuation context. Subscription growth and regulatory/privacy risks could moderately influence earnings trajectory and investor sentiment.

Cellebrite DI Ltd. initiates plans to redomicile in the United States. Redomiciling in the United States constitutes a major strategic corporate action with potential regulatory and market effects.

Cellebrite DI Ltd. names CTO Chris Wade to lead Cellebrite Labs, directing greater resources toward mobile research. Internal leadership move to prioritize mobile research supports incremental product development.

Cellebrite DI Ltd. initiates plans to redomicile in the United States. Redomiciling represents a strategic corporate relocation that may affect regulatory standing and market access but does not alter core operations.

Cellebrite Guardian completes IRAP assessment and achieves PROTECTED level for Australian government agencies. Certification win enables sales of Cellebrite Guardian to Australian government agencies.

Cellebrite announced its U.S. subsidiary Cellebrite Federal Solutions, Inc. (CFSI) earned Cybersecurity Maturity Model Certification (CMMC) Level 2, verified by a Certified Third-Party Assessment Organization. CMMC Level 2, a Department of War (DoW) framework for contractors handling DoW Controlled Unclassified Information (CUI), requires 110 security practices across 14 control families, including access control, incident response, risk management, system and communications protection, and auditing. Chief operating officer and head of federal strategy Philip O'Reilly said the milestone signals to federal customers that protecting sensitive information is paramount; it complements recent FedRAMP High authorization for Cellebrite Government Cloud and underscores DoW's move toward mandatory third-party assessments. CFSI is positioned as a trusted, security-first partner, leveraging Cellebrite's technology portfolio and federal-domain expertise to win federal missions. Gaining CMMC Level 2 and FedRAMP High strengthens federal market access and security credentials, potentially enhancing Cellebrite's competitive position and revenue from DoW agencies.

Cellebrite (Nasdaq: CLBT) said its subsidiary Cellebrite Federal Solutions, Inc. (CFSI) earned Cybersecurity Maturity Model Certification (CMMC) Level 2, assessed by a Certified Third-Party Assessment Organization (C3PAO) under the Department of War framework for handling DoW Controlled Unclassified Information. Level 2 requires 110 security practices across 14 control families, including access control, incident response, risk management, system and communications protection, and auditing and accountability. The certification follows Cellebrite’s FedRAMP High authorization for its Government Cloud and positions CFSI among the top 3% of organizations meeting the standard. SVP and COO Philip O'Reilly said the milestone demonstrates protection of sensitive federal data and strengthens the ability to serve DoW and federal agencies. CFSI is U.S.-based and FOCI-mitigated, integrating Cellebrite’s technology with federal-domain expertise for mission-ready digital intelligence. Advances federal market access and credibility, potentially increasing government revenue and pipeline.

Cellebrite Federal Solutions achieved the U.S. Department of War's advanced cybersecurity standard to strengthen secure federal operations. Subsidiary certification supports expanded federal contract eligibility without altering core business trajectory.

Cellebrite launches Portable Tactical Extraction Kit (C-TEK) to deliver battlefield intelligence capabilities directly to armed forces. New military-focused extraction kit expands Cellebrite addressable market into defense sector with potential revenue growth.

Cellebrite DI Ltd. faces CEO change and lowered guidance alongside strong gains in AI and FedRAMP initiatives. CEO transition and guidance cuts introduce short-term pressure while AI and FedRAMP gains provide offsetting positive momentum.

Cellebrite DI Ltd. (CLBT) held its Q2 2026 earnings call to review financial results, operational progress, and forward guidance. Q2 2026 earnings data and outlook directly shape investor views and near-term stock trajectory for CLBT.

Cellebrite DI Ltd. makes its Genesis for Enterprise solution generally available with expanded regional availability across additional global markets. General availability of a key enterprise product plus global rollout can drive revenue growth and strengthen competitive positioning.

Cellebrite DI Ltd. announces general availability of Cellebrite Genesis for Enterprise with expanded regional availability to additional global markets. Product rollout and geographic expansion moderately strengthens enterprise offerings and revenue channels but does not alter core trajectory.

Cellebrite DI Ltd. made Genesis for Enterprise generally available and expanded its regional availability to more global markets. Genesis for Enterprise availability expansion can increase enterprise sales and market reach.

Cellebrite (CLBT) holds a compounding track record strong enough to require an upward re-rating of its enterprise software valuation. Cellebrite's sustained performance gains point to major shifts in market perception and valuation multiples.

Cellebrite DI Ltd. cut its financial guidance and replaced its CEO, prompting questions on whether the stock is now undervalued. Guidance reductions combined with CEO turnover usually trigger major investor reassessments and valuation swings.

Cellebrite DI lowered its 2026 outlook and appointed a new CEO, raising questions about a reset to its AI narrative. Lowered 2026 outlook and new CEO create moderate pressure on Cellebrite revenue trajectory and leadership stability.

Cellebrite DI Ltd. (CLBT) names Shiven Ramji as next CEO. New CEO appointment at Cellebrite DI Ltd. may shift strategy and affect market sentiment.

Cellebrite shares plunged 29% after missing earnings and cutting 2026 revenue guidance. Missed earnings and reduced 2026 revenue guidance indicate major setbacks to financial trajectory and investor outlook.

Cellebrite DI Ltd. held its Q2 2026 earnings call covering financial results, operational updates and forward guidance. Quarterly earnings data and outlook typically produce moderate short-term effects on valuation and sentiment.

Cellebrite DI Ltd's Q2 2026 earnings call showed ARR missed guidance with details on full-year outlook. ARR missing guidance signals short-term pressure on revenue growth and market sentiment.

Cellebrite DI Ltd. held Q2 earnings call covering financial results, operational updates and forward outlook. Quarterly earnings data typically drive short-term share price moves without altering long-term trajectory.

Cellebrite expands its exclusive SkySafe partnership to deliver immediate drone detection and airspace intelligence for digital investigations at scale. Partnership expansion adds drone detection capabilities to Cellebrite's investigative tools and competitive positioning.

Cellebrite expands exclusive SkySafe partnership to enable immediate drone detection and airspace intelligence for large-scale digital investigations. Expanded SkySafe partnership adds drone detection features strengthening Cellebrite's digital investigation offerings.

Cellebrite expands exclusive SkySafe partnership to deliver immediate drone detection and airspace intelligence for digital investigations at scale. Partnership expansion adds drone detection and airspace intelligence capabilities to Cellebrite offerings.

DA Davidson states Cellebrite (CLBT) has a large, growing total addressable market that is likely understated. Positive analyst view on Cellebrite's market size can lift near-term investor sentiment without altering core operations.

Cellebrite DI Ltd. announces general availability of its Genesis platform, described as ushering in the new age of investigations. Genesis general availability constitutes a major product launch that can significantly shift competitive positioning and investor sentiment.

Cellebrite DI Ltd. launches Genesis platform now generally available, introducing new capabilities for digital investigations. Major new product launch advances core offerings and strengthens competitive position in digital forensics.

Cellebrite DI Ltd. launches Genesis platform now generally available, delivering new digital investigation capabilities to law enforcement and enterprise customers. Genesis release constitutes a major product launch that can materially strengthen Cellebrite's competitive position and revenue trajectory.

Cellebrite DI targets AI, cloud solutions and FedRAMP approval to meet rising demand for digital investigations. Focus on AI, cloud and FedRAMP compliance signals major strategic moves that can reshape growth trajectory.